BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2461906)

  • 1. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
    Ehrly AM; Seebens H; Saeger-Lorenz K
    Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
    Ernst E; Kollar L; Matrai A
    Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
    Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
    Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of low molecular weight hydroxyethyl starch (HES 40) in comparison with Ringer solution on oxygen tension in skeletal muscles of infected patients].
    Steinberg B; Kochs E; Bause H; Schulte am Esch J
    Anasth Intensivther Notfallmed; 1989 Dec; 24(6):377-81. PubMed ID: 2482677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
    Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organ blood supply and oxygenation during limited isovolemic hemodilution with 6% HES 200/0.62 and 6% Dextran 70].
    Brückner UB; Messmer K
    Anaesthesist; 1991 Aug; 40(8):434-40. PubMed ID: 1719841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodilution in patients with stage IIb peripheral arterial occlusive disease: prospective randomized double-blind comparison of middle-molecular weight hydroxyethyl starch and low-molecular weight dextran solution].
    Kiesewetter H; Jung F; Blume J; Gerhards M
    Klin Wochenschr; 1987 Apr; 65(7):324-30. PubMed ID: 2438451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
    Brehme S; Keysser G; Turowski A; Schmidt HH
    Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease.
    Ernst E; Matrai A; Kollar L
    Angiology; 1989 May; 40(5):479-83. PubMed ID: 2468300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of stepwise hypervolemic versus isovolemic hemodilution in patients with intermittent claudication on muscle oxygen pressure during exercise].
    Höffkes HG; Saeger-Lorenz K; Ehrly AM
    Vasa; 1991; 20(2):109-18. PubMed ID: 1877329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorheologic changes in preoperative hemodilution during total hip replacement. Randomized study comparing hydroxyethyl starch 200,000/0.62 (HES) and a dextran 60,000].
    Lartigue B; Barre J; Nguyen P; Potron G
    J Mal Vasc; 1994; 19(1):27-31. PubMed ID: 7517991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hemodilution with 10% hydroxyethyl starch solution (MW 200,000/9.5) on the flow properties of blood, arterial blood gases and conjunctival oxygen partial pressure in patients with cerebral infarct].
    Staedt U; Hütt M; Herrmann B; Seufzer U; Leweling H
    Infusionstherapie; 1989 Jun; 16(3):107-12. PubMed ID: 2474508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of infusion with hydroxyethyl starch and low molecular weight dextran on cerebral blood flow and hemorheology in normal baboons.
    Tsuda Y; Hartmann A; Weiand J; Solymosi L
    J Neurol Sci; 1987 Dec; 82(1-3):171-80. PubMed ID: 2450177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks].
    Haass A; Kroemer H; Jäger H; Müller K; Decker I; Wagner EM; Schimrigk K
    Dtsch Med Wochenschr; 1986 Oct; 111(44):1681-6. PubMed ID: 2429818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal hematocrit in patients with intermittent claudication. Exercise-induced muscle tissue oxygen pressure after stepwise hemodilution.
    Höffkes HG; Saeger-Lorenz K; Ehrly AM
    Acta Med Austriaca; 1991; 18 Suppl 1():16-9. PubMed ID: 1950385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on the flow property and coagulation of whole blood in vivo].
    Klose R; Feldmann U; Hoecker P
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():37-42. PubMed ID: 2439457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
    Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
    Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb.
    Kiesewetter H; Blume J; Jung F; Spitzer S; Wenzel E
    J Intern Med; 1990 Feb; 227(2):107-14. PubMed ID: 1688914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.